TS, COX2, EGFR, MSH6, MLH1 and p53 expression, as measured through immunohistochemical analysis, was not associated with the clinical-pathological factors of the patients with colorectal adenocarcinoma studied, except for MLH1 in some cases. This evidence concerns the gene EGFR and colorectal adenocarcinoma.